Sobering Signal: Current AI Cannot Fundamentally Remodel the Biology of Medicine
zakkohane · x · 2026-08-01
Harvard Medical School professor Isaac Kohane shares a recent study on inflammation and cardiovascular disease (the ZEUS trial), noting it as a sobering signal for those expecting AI to easily solve medicine. The findings suggest that due to the extreme complexity of human biology, current ab initio thinking—whether human or AI—struggles to fundamentally crack intricate medical disease mechanisms.
More from AGI Musings
- OpenAI Economics Team Outlines Methodology for Measuring AI's Economic Impact — soumitrashukla9 · 2026-08-01
- The Meaning Crisis in the AI Era: Multiscale Causality and Metacognitive Gradients — ryan_t_lowe · 2026-08-01
- Michael Nielsen's New Essay Explores Expanding the Space of Moral Imagination — michael_nielsen · 2026-08-01
- First PhD Generation to Train Alongside Powerful AI: UCLA Neuroscience Calls for Academic Rigor — anne_churchland · 2026-08-01
- DeepMind Scientist: AI May Take Jobs, but Human Intuition and Meaning Will Remain — ryan_t_lowe · 2026-08-01
- Is Paying for University Preposterous in the Age of AI? — dbasch · 2026-08-01